1. AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations

2. 2 Everyone cares about health Young or old. Rich or poor. Around the world. It’s one thing that we all have in common AstraZeneca is here to make a difference to people’s health

3. 3 Doctors and patients 70 years of innovative medicines Touching the lives of many people People who pay for healthcare Our shareholders The wider community Our employees

4. 4 Our focus is on six areas of medicine Cancer Cardiovascular disease Infection Gastrointestinal disease Neurological disorders Respiratory & inflammatory conditions

5. Top 8% Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes. We employ over 61,000 people 47% in Europe, 30% in the Americas, 23% in Asia, Africa and Australasia We invest over $4 billion in R&D each year and have over 15,500 people in our R&D organisation In 2010, our worldwide sales totalled $33.3 billion).

6. |Pre-Pharmacy Society Meeting – November 10, 20116 Thank you for your time and interest For more information about AstraZeneca and activities worldwide, visit astrazeneca.com